Organiser

SCRI was established in 2008 as the national academic clinical research organisation to enhance the standards of clinical research in Singapore by developing core capabilities, infrastructure and scientific leadership for clinical research.

In 2021, SCRI was appointed as the national coordinating body to implement the national clinical trial strategy and enhance Singapore's clinical trial ecosystem.

This is accomplished through the deployment of innovative technologies and processes, and strategic coordination of ecosystem capabilities and infrastructure to achieve synergies that will enhance the clinical research ecosystem aimed towards a healthier community and better patient outcomes.

SCRI's key pillars include:
1. Clinical Research Operations
2. Clinical Research Networks
3. Academic Research Partnerships
4. SCRI Academy

SCRI is a programme of the Consortium for Clinical Research and Innovation, Singapore (CRIS). SCRI is supported by the Singapore Ministry of Health through the NMRC Office, MOH Holdings Pte Ltd under the NMRC Enablers and Infrastructure Support for Clinical Trials-related Activities funding initiative (MOH-001144).

For more information, please visit the SCRI website here.